TABLE 1

Characteristics of 23 Consecutive Patients with Known or Suspected Amyloidosis and Findings on 99mTc-Aprotinin Scintigraphy

Patient no.SexAge (y)Type of amyloidosis/coexisting malignant disease and clinical conditions99mTc-Aprotinin accumulations on scintigraphyBiopsy or autopsy positive or negative*Symptoms on scintigraphy
1F86AL amyloidosis/IgGκ multiple myelomaHands+
Tongue++
Submandibular glands++
Heart, intestines
2M39AL amyloidosis renis/nephrotic syndrome, multiple myeloma (κ light-chain disease)Heart++
Paraaortic lymph nodes+
Liver+
Spleen+
3M62AL amyloidosis/plasmacytoma with amyloidosis, multiple myeloma (λ light-chain disease)Left eye region+
Upper mediastinum++
Left shoulder+
Liver
4M59AL amyloidosis/IgGκ M component, MGUSHeart, liver
Spleen
——+ rectum, + bone marrow, + lip
5M64AL amyloidosis renis/(λ light chain in urine)Heart+
Right lung/pleura+
Liver+
Spleen+
6F78AL amyloidosis/initially plasmacytoma, multiple myeloma (κ light-chain disease)Both pleura/lungs
Left maxillary sinus++
Calvarium++
Right shoulder+
Left femur
7F66AL amyloidosis renis/multiple myeloma IgAλLungs
Liver, intestines
8F70Clinically evident amyloidosis/multiple myeloma (λ light-chain disease)Liver, spleen
9F56Localized amyloidosis in plica vocalis/no myelomaLiver
+ plica vocalis+
10F66Clinically evident amyloidosis/IgAλ multiple myelomaHeart+§
Tongue+
Liver
11F75AL amyloidosis renisLiver++
Spleen
12F45Localized amyloidosis in biopsy of sural nerve+ of sural nervePolyneuropathy
13M55AL amyloidosis/IgGκ multiple myelomaHeart++
14M50Hereditary amyloidosisHeart++
Pleura, intestines
15M73AL amyloidosis renis/IgMκ macroglobulinemia WaldenströmLungs
Liver, spleen
Intestines
16F57Hereditary amyloidosisHeart+
Lungs+
Liver, pleura
17F60Clinically evident amyloidosis/IgGκ multiple myelomaLungs+
Liver
18F58AL amyloidosis/macroglobulinemia Waldenström, and cold-agglutinin syndromeLiver+
Spleen, intestines, lungs
All major joints+
Metacarpophalangeal regions and fingers+ pathologic fracture of right femur, + bone marrow+
19F58Localized amyloidosis in bronchial biopsyLungs, liver
20M54AL amyloidosis/IgMκLiver++
Spleen+
Intestines+
+ heart, + alveolar walls, + vascular walls in lungs, + bone marrow+
21F67AL amyloidosis/nephrotic syndrome IgAλLiver+
Spleen, lungs
Shoulders, nasopharynx
22M53AL amyloidosis/multiple myeloma, gastrointestinal and bone marrow amyloid depositsTongue+
Pleura
Liver, spleen
23F57AL amyloidosis of lungsLungs++
Liver
  • * Positive (+) or negative in relation to scintigraphic findings.

  • Positive (+) = symptoms on scintigraphy; negative (−) = no symptoms on scintigraphy.

  • Had scintigraphy performed twice within 6 mo after chemotherapy and autologous transplantation of bone marrow and had clinical, paraclinical, and scintigraphic reduction of tumor size in mediastinum.

  • § After medical treatment with alkaran and prednisolone, patient had regression of symptoms.

  • Had scintigraphy performed twice within 6 mo after chemotherapy and autologous transplantation of bone marrow with remission of multiple myeloma, but no change in cardiac uptake on scintigraphy or cardiac performance.

  • Cardiac region was not sufficiently covered by scintigraphic study.

  • MGUS = monoclonal gammopathy of unknown significance.